|Videos|March 14, 2017
Kathleen N. Moore Discusses New PARP Inhibitors for Ovarian Cancer
Author(s)Kathleen N. Moore M.D.
Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.
Advertisement
Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Clock Touches: An Advanced Balance Exercise for Patients with Cancer
2
Wildfire Smoke and Cancer Risk: What Patients Should Know
3
Biomarker Testing for Cancer: What Patients Should Know
4
Balance Exercises for Patients With Cancer: How the Single-Leg Stand Builds Stability
5